2 – Should aspirin be stopped pre-operatively in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10840
3 – What is the optimal management of patients who are on antiplatelet medications prior to an elective orthopaedic procedure? https://icmphilly.com/?page_id=10880
4 – What is the optimal management of patients who are on antiplatelet medications prior to an emergency orthopaedic procedure? https://icmphilly.com/?page_id=10890
5 – When should chronic anticoagulation be stopped in patients undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10305
6 – Should bridging by an injectable anticoagulation be considered in patients who are on chronic anticoagulation prior to undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10467
7 – Should the VTE prophylaxis be altered in patients undergoing orthopaedic procedures who develop wound-related problems? https://icmphilly.com/?page_id=10501
8 – Is there an association between pulmonary embolus and secondary pulmonary hypertension after major orthopaedic surgery? https://icmphilly.com/?page_id=10555
9 – Are there adverse consequences of not treating acute lower extremity DVT in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10530
10 – Does the development of a hematoma as a result of the administration of VTE prophylaxis increase the risk of subsequent arthrofibrosis? https://icmphilly.com/?page_id=10917
11 – Does the administration of VTE prophylaxis to patients undergoing orthopedic procedures increase the rate of post-operative non-VTE complications? https://icmphilly.com/?page_id=10731
12 – Does the administration of VTE prophylaxis increase the risk for epidural hematoma in patients undergoing orthopaedic procedures? If so, are there differences between the various agents? https://icmphilly.com/?page_id=10559
13 – Does the administration of VTE prophylaxis increase the risk for intracranial bleeding in patients undergoing orthopaedic procedures? If so, are there differences between the various prophylactic agents? https://icmphilly.com/?page_id=10693
14 – Should venous thromboembolism (VTE) screening be performed in asymptomatic patients undergoing orthopaedic surgery? https://icmphilly.com/?page_id=10497
15 – Are there specific clinical findings that are indicative of lower extremity DVT? https://icmphilly.com/?page_id=11120
16 – Are there any serological biomarkers for the diagnosis of DVT/PE? https://icmphilly.com/?page_id=10567
17 – What is the optimal imaging modality for detection of upper and lower extremity DVT for patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10437
18 – What is the most optimal imaging modality for diagnosis of PE following orthopaedic surgery? https://icmphilly.com/?page_id=11126
19 – What is the cost efficacy of each VTE prophylactic agent that may be used in patients undergoing orthopaedic surgery? https://icmphilly.com/?page_id=11154
20 – Do venous filling defects seen on cross-sectional imaging of the lung always represent a PE? https://icmphilly.com/?page_id=10425
21 – Is there a role for lower extremity venograms for the diagnosis of lower extremity DVT? https://icmphilly.com/?page_id=10667
23 – What are the indications for use of an IVC filter in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11158
24 – Is there a role for the use of intermittent compression devices as VTE prophylaxis for patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11162
25 – Does post-operative rehabilitation protocol such as early ambulation influence the incidence of VTE after orthopaedic procedures? https://icmphilly.com/?page_id=10617
26 – Is there a role for the use of compression stockinette in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10375
27 – Is there a difference between different types of intermittent pneumatic compression devices (IPCD)? https://icmphilly.com/?page_id=11115
28 – Do clinical practice guidelines set the standard of care for VTE prophylaxis? https://icmphilly.com/?page_id=11166
29 – Are there specific contraindications for the administration of each VTE prophylactic agent? https://icmphilly.com/?page_id=10748
30 – Are there differences between various VTE prophylaxis in terms of patient compliance/adherence? https://icmphilly.com/?page_id=10760
31 – Can NSAID be used as prophylactic agents against VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10508
32 – Can NSAID be co-administered with aspirin, when used as a VTE prophylaxis, in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10713
33 – What VTE prophylaxis should be administered to a patient who is allergic to aspirin? https://icmphilly.com/?page_id=10190
34 – Is there a difference between low dose and regular dose aspirin for the prevention of VTE following orthopaedic procedures? https://icmphilly.com/?page_id=10194
36 – Is there a role for sequential combination VTE prophylaxis in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10513
37 – Are there differences between various injectable agents for pharmacological VTE prophylaxis with regard to efficacy and safety profile? https://icmphilly.com/?page_id=11175
38 – Should the dose of LMWH for the prevention of VTE be weight-adjusted? https://icmphilly.com/?page_id=10571
39 – What is the optimal timing for the start of LMWH as a VTE prophylaxis in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10350
40 – Is there a role for bridging with another therapeutic anticoagulant after orthopaedic surgery when warfarin is used for VTE prophylaxis? https://icmphilly.com/?page_id=10764
41 – Are there differences between various factor Xa inhibitors for management of VTE with regard to efficacy and safety profile? https://icmphilly.com/?page_id=10718
42 – Are there any blood tests that can be used to monitor the activity/efficacy of factor Xa inhibitors used as VTE prophylaxis? https://icmphilly.com/?page_id=10176
43 – Does the availability of reversal agents influence the choice of a selected chemical VTE prophylaxis agent? https://icmphilly.com/?page_id=11179
44 – Does warfarin cause hypercoagulable state during initial administration? https://icmphilly.com/?page_id=10198
45 – Is intraoperative heparin effective and safe to prevent postoperative VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11185
46 – Do all emboli detected on cross-sectional imaging of the lung lead to the same degree of oxygenation compromise (hypoxia)? https://icmphilly.com/?page_id=10575
47 – Are there genetic predisposing factors for VTE? https://icmphilly.com/?page_id=10595
48 – What is the optimal duration of VTE prophylaxis following major orthopaedic procedures? https://icmphilly.com/?page_id=11446
49 – Does the risk of post-operative wound problems in patients undergoing orthopaedic procedures differ between various VTE prophylactic agents? https://icmphilly.com/?page_id=11195
50 – What are the indications for seeking a thrombosis specialist or a hematology consult for VTE prevention, in patients undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10517
51 – Is there a correlation between age and the risk of VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10331
52 – Is there a role for stratification of patients undergoing orthopaedic procedures for risk of bleeding? If so, should VTE prophylaxis be altered based on bleeding risk profile? https://icmphilly.com/?page_id=10622
53 – Is there a validated risk stratification scoring system that can be used for determining VTE risk of a patient undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10325
54 – Is there a risk stratification system for predicting major bleeding events following orthopaedic procedures? https://icmphilly.com/?page_id=11214
55 – Are patients with prior history of COVID – 19 who undergo orthopaedic procedures at an increased risk of VTE? If so, should their post-operative anticoagulation regiment be altered? https://icmphilly.com/?page_id=11204
56 – Does the risk for VTE increase after COVID – 19 vaccination? https://icmphilly.com/?page_id=11210
57 – Is the risk of VTE following orthopaedic procedures related to ethnicity or race? If yes, should VTE prophylaxis be altered or changed based on race and/or ethnicity? https://icmphilly.com/?page_id=10539
58 – Is there a definite association between BMI and VTE? https://icmphilly.com/?page_id=10671
59 – Does the type of anesthesia administered influence the risk of VTE in orthopedic surgery? https://icmphilly.com/?page_id=10210
60 – Does administration of tranexamic acid (TXA) to a patient undergoing orthopaedic procedures increase the risk of subsequent VTE? https://icmphilly.com/?page_id=11224
61 – Does tourniquet applied to the lower extremity influence the incidence of post-operative VTE? https://icmphilly.com/?page_id=10526
62 – Does tourniquet applied to upper extremity influence the incidence of post-operative VTE? https://icmphilly.com/?page_id=10521
63 – Does the duration of surgery influence the incidence of postoperative VTE? https://icmphilly.com/?page_id=10445
64 – Does the volume of intraoperative blood loss influence the incidence of post-operative VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10234
65 – Does administration of allogeneic blood transfusion influence the incidence of post-operative VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10311
66 – Does the use of PMMA cement during orthopaedic procedures influence the risk of subsequent VTE? https://icmphilly.com/?page_id=10580
67 – Does the intra-operative positioning of a patient undergoing orthopaedic surgery influence the risk of subsequent VTE? https://icmphilly.com/?page_id=10371
68 – Does lower extremity deep venous thrombosis arising after total joint arthroplasty propagate to cause pulmonary embolus? https://icmphilly.com/?page_id=11450
69 – Does the type (DVT vs. PE) or timing (remote vs. recent) of prior VTE influence the risk of subsequent VTE following orthopaedic procedures? https://icmphilly.com/?page_id=10493
70 – Should a patient with active lower extremity DVT undergo an orthopaedic procedure? https://icmphilly.com/?page_id=11111
71 – Is administration of any VTE prophylaxis effective in reducing the risk of fatal PE? https://icmphilly.com/?page_id=10535
72 – How long after a diagnosed DVT and/or PE can a patient undergo elective orthopaedic procedure? https://icmphilly.com/?page_id=10626
73 – When do VTE episodes occur after orthopaedic procedures? https://icmphilly.com/?page_id=10367
74 – What endpoint should be used to determine the efficacy of a VTE prophylactic agent? https://icmphilly.com/?page_id=11454
75 – Does the location of PE in the lung, as detected by imaging, influence the type of anticoagulation treatment that may be administered? https://icmphilly.com/?page_id=10654
76 – How should patients with post-operative distal DVT be managed? https://icmphilly.com/?page_id=10658
77 – How should patients with post-operative proximal (popliteal or supra-popliteal) DVT be managed? https://icmphilly.com/?page_id=10689
78 – How should a patient with a soleal vein thrombosis detected after an orthopaedic procedure be managed? https://icmphilly.com/?page_id=11458
79 – In patients with confirmed acute distal DVT, should a mechanical compression device be discontinued in the affected limb? https://icmphilly.com/?page_id=11462
80 – Does the presence of varicosities and/or superficial lower extremity thrombosis increase the risk of VTE in patients undergoing orthopedic procedures? https://icmphilly.com/?page_id=10450
81 – (A) Do oral contraceptive medications increase the risk of VTE? (B) If so, should they be stopped prior to orthopaedic procedures? https://icmphilly.com/?page_id=11466
82 A – What is the optimal VTE prophylaxis modality for patients with bleeding disorders such as hemophilia or Von Willebrand disease? https://icmphilly.com/?page_id=11473
82 B – What is the optimal VTE prophylaxis modality for patients with clotting disorders such as thrombophilia? https://icmphilly.com/?page_id=11477
83 – Should the perioperative VTE prophylaxis of a patient undergoing orthopaedic procedure and diagnosed with acute atrial fibrillation be altered? https://icmphilly.com/?page_id=11487
84 – Do patients with an underlying diagnosis of infection (local or systemic) undergoing orthopaedic procedures have an elevated risk for subsequent VTE? https://icmphilly.com/?page_id=10685
85 – What is the most optimal VTE prophylaxis for patients who are on strict bed rest pre- or post-operatively? https://icmphilly.com/?page_id=11491
86 – Are patients, who traveled on airplanes or had long car rides prior to surgery, at an increased risk of VTE? If so, what is the optimal interval between travel and surgery? https://icmphilly.com/?page_id=11496
87 – What is the most optimal management of a patient with elevated coagulation parameters, such as high INR, undergoing emergency orthopaedic surgery? https://icmphilly.com/?page_id=11503
88 – Does a history of prior VTE influence the rate of subsequent VTE in pts undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11507
89 – Do oral hormonal therapy, used for cancer management, increase the risk of post-operative VTE in patients undergoing orthopaedic procedures? If so, should they be stopped prior to surgery? https://icmphilly.com/?page_id=11511
90 – Does VTE prophylaxis in patients with chronic kidney disease need to be altered when undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11526
91 – Does VTE prophylaxis in patients with chronic liver disease need to be altered when undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11530
92 – Do all orthopaedic procedures have the same risk profile for DVT? https://icmphilly.com/?page_id=11534
93 – Should the post-operative rehabilitation of a patient with confirmed PE be modified? https://icmphilly.com/?page_id=11538
94 – Should the post-operative rehabilitation of patients who have confirmed symptomatic DVT be modified? https://icmphilly.com/?page_id=11543
95 – What is the most appropriate method to monitor patients with confirmed post-operative VTE? https://icmphilly.com/?page_id=11547
96 – Is there a role for thrombolysis in the management of patients with post-operative VTE? https://icmphilly.com/?page_id=11551
97 – Is there a role for empirical treatment of patients with suspected, but not confirmed, VTE in the post-operative period? https://icmphilly.com/?page_id=10884
98 – Are certain patients identified to be at greater risk for venous thromboembolism than others? https://icmphilly.com/?page_id=10697
99 – If a patient is in an “increased risk” group for the development of VTE, are there certain agents which have increased efficacy over other anticoagulants? https://icmphilly.com/?page_id=10872
131 – Is a foot pump as effective as a lower extremity intermittent compression device for VTE prophylaxis? https://icmphilly.com/?page_id=11229
206 – Is Thromboelastography (TEG) useful in predicting the risk of VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10701